About SunnyBay BioTech
SunnyBay BioTech is a private company based in Fremont, California, incorporated in 2022 in Delaware. It has reported $2,230,915 raised in one offering on Form D since January 2023. Its chief executive is Feng Wang-Johanning.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 11, 2023 | Jan 27, 2023 | $2,230,915of $5.9M target | 3 | $743K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on SunnyBay BioTech's Form D filed Jan 27, 2023.
FJ
Feng Wang-Johanning
Chief Executive Officer and director
XC
Xiangmin Cui
Director
Also a director at Baylor Genetics, ImmPACT Bio USA and LevitasBio and an executive officer, director and promoter at Decheng Capital Global Life.
GJ
Gary Johanning
Executive officer
PC
Peter Colabuono
Director